Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126.
about
Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastographyThe role of tumour-derived iNOS in tumour progression and angiogenesisInducible nitric oxide synthase (iNOS) mediates the early increase of blood supply (EIBS) in colon carcinogenesis.Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules.Inhibition of Raf-MEK-ERK and hypoxia pathways by Phyllanthus prevents metastasis in human lung (A549) cancer cell lineDetecting microvascular changes in the mouse spleen using optical computed tomography.NOS-2 signaling and cancer therapy.A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.Investigating the role of tumour cell derived iNOS on tumour growth and vasculature in vivo using a tetracycline regulated expression system.Gr-1+CD11b+ cells facilitate Lewis lung cancer recurrence by enhancing neovasculature after local irradiation.Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia.
P2860
Q30764503-0510BB8E-5E4E-4BC9-811A-347AD4E34F0DQ33765559-8B0AB64F-D66B-42F3-84A3-ED1E5101BD22Q34033048-E79CE436-4706-4D6F-B7BF-5E3D77AF074EQ34902676-E3319A53-A31A-43E3-B91D-9F45E97A189CQ35020574-66964562-DAD6-472F-8367-86A6AA106D73Q35974239-4203A297-F3E1-4284-858B-533E86D3F077Q38020147-E5A97F03-DB7C-4B9C-A272-350B97A9D400Q38652256-B316E051-145E-4B1D-BEE5-0906EBB14DA9Q38804591-0D59532E-B68C-4FF5-BB30-4DE01733A975Q39030742-7B7A532D-3ED6-43FC-8A0B-DED041FF55A3Q42141212-93F10634-CA54-4989-9CF4-341A6FB08FFF
P2860
Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Tumour overexpression of induc ...... cular disrupting agent ZD6126.
@ast
Tumour overexpression of induc ...... cular disrupting agent ZD6126.
@en
type
label
Tumour overexpression of induc ...... cular disrupting agent ZD6126.
@ast
Tumour overexpression of induc ...... cular disrupting agent ZD6126.
@en
prefLabel
Tumour overexpression of induc ...... cular disrupting agent ZD6126.
@ast
Tumour overexpression of induc ...... cular disrupting agent ZD6126.
@en
P2093
P50
P1476
Tumour overexpression of induc ...... scular disrupting agent ZD6126
@en
P2093
Elizabeth R Cullis
John R Griffiths
Susan E Ashton
P356
10.1016/J.MVR.2006.01.004
P577
2006-03-10T00:00:00Z